Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction
Authors:
- Ana Z. GonzalezAGAna Z. Gonzalez
- John EksterowiczJEJohn Eksterowicz
- Michael D. BartbergerMBMichael D. Bartberger
- Hilary P. BeckHBHilary P. Beck
- Jude CanonJCJude Canon
- Ada ChenACAda Chen
- David ChowDCDavid Chow
- Jason DuquetteJDJason Duquette
- Brian M. FoxBFBrian M. Fox
- Jiasheng FuJFJiasheng Fu
- Jonathan B. HouzeJHJonathan B. Houze
- 4 March 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 57 (6) , 2472-2488
Abstract
We previously reported the discovery of AMG 232, a highly potent and selective piperidinone inhibitor of the MDM2–p53 interaction. Our continued search for potent and diverse analogues led to the discovery of novel morpholinone MDM2 inhibitors. This change to a morpholinone core has a significant impact on both potency and metabolic stability compared to the piperidinone series. Within this morpholinone series, AM-8735 emerged as an inhibitor with remarkable biochemical potency (HTRF IC50 = 0.4 nM) and cellular potency (SJSA-1 EdU IC50 = 25 nM), as well as pharmacokinetic properties. Compound 4 also shows excellent antitumor activity in the SJSA-1 osteosarcoma xenograft model with an ED50 of 41 mg/kg. Lead optimization toward the discovery of this inhibitor as well as key differences between the morpholinone and the piperidinone series will be described herein.Keywords
This publication has 33 references indexed in Scilit:
- Inhibitors of MDM2 and MDMX: A Structural PerspectiveFuture Medicinal Chemistry, 2009
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Regulating the p53 pathway: in vitro hypotheses, in vivo veritasNature Reviews Cancer, 2006
- Inhibiting the p53–MDM2 interaction: an important target for cancer therapyNature Reviews Cancer, 2003
- Surfing the p53 networkNature, 2000
- p53 and Human Cancer: The First Ten Thousand Mutations1999
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor ProteinMolecular and Cellular Biology, 1996
- p53, guardian of the genomeNature, 1992
- Amplification of a gene encoding a p53-associated protein in human sarcomasNature, 1992